Podcast With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown October 01, 2025Vol.51 No.35
Guest Editorial Population-based cancer surveillance is a national treasure at risk September 26, 2025Vol.51 No.35By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash
NCI Anthony G. Letai to be named NCI directorThe Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say September 25, 2025Vol.51 No.35By Claire Marie Porter and Paul Goldberg
Podcast Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes. September 24, 2025Vol.51 No.34
NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium September 19, 2025Vol.51 No.34By Paul Goldberg
NCI NCI releases names of members of ad hoc working group—filling the void left by BSA September 19, 2025Vol.51 No.34By Sara Willa Ernst
In Brief UCSF awarded $12M SPORE grant to study cancer outcomes for meningioma, prostate cancer, and breast cancer September 19, 2025Vol.51 No.34
In Brief NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards September 19, 2025Vol.51 No.34
